A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

PersonnelChange in Siegfried's Executive Committee 17.07.2025 / 06:30 CET/CESTMedia ReleaseZofingen, July 17, 2025Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing ...

The Astellas Pharma executive was sentenced to 3½ years in a case that has added strain to relations between Tokyo and ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

As supply chain disruption persists in pharma, global logistics providers with the expertise to overcome any challenge are essential.

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.

Health insurance companies use AI to decide which health care treatment to cover. State laws and federal agencies are now ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

What a dog. A Democratic congressman who is trying to impeach President Trump was once accused of abandoning 118 beagles inside his pharmaceutical testing lab when it went bankrupt. Rep. Shri Thane… ...

BioMarin (BMRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.